Time-resolved fluorescence resonance energy transfer and surface plasmon resonance-based assays for retinoid and transthyretin binding to retinol-binding protein 4

Analytical Biochemistry

Volumn 392, Issue 2, 2009, Pages 162-168

  Sharif, Orzala ^a   Hu, Huiyong ^a   Klock, Heath ^a   Hampton, Eric N ^a   Nigoghossian, Edward ^a   Knuth, Mark W ^a   Matzen, Jason ^a   Anderson, Paul ^a   Trager, Richard ^a   Uno, Tetsuo ^a   Glynne, Richard J ^a   Azarian, Sassan M ^a   Caldwell, Jeremy S ^a   Brinker, Achim ^a  

^a GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

Author keywords

Binding assay; Diabetes; Fenretinide; Macular degeneration; RBP4; TR FRET

Indexed keywords

BINDERS; BINDING ENERGY; ENERGY TRANSFER; FORSTER RESONANCE ENERGY TRANSFER; MEDICAL PROBLEMS; MOLECULES; OPHTHALMOLOGY; PLASMONS; PROTEINS; RESONANCE;

BINDING ASSAYS; FENRETINIDE; MACULAR DEGENERATION; RBP4; TR-FRET;

SURFACE PLASMON RESONANCE;

FENRETINIDE; PREALBUMIN; RETINOIC ACID DERIVATIVE; RETINOID; RETINOL BINDING PROTEIN 4;

ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; FLUORESCENCE RESONANCE ENERGY TRANSFER; IC 50; MICROTITER PLATE ASSAY; MOLECULAR PROBE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE;

EID: 67650495019     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2009.05.038     Document Type: Article

References (28)

1. Berni R., Clerici M., Malpeli G., Cleris L., and Formelli F. Retinoids: in vitro interaction with retinol-binding protein and influence on plasma retinol. FASEB J. 7 (1993) 1179-1184
2. Zanotti G., Marcello M., Malpeli G., Folli C., Sartori G., and Berni R. Crystallographic studies on complexes between retinoids and plasma retinol-binding protein. J. Biol. Chem. 269 (1994) 29613-29620
3. Zanotti G., and Berni R. Plasma retinol-binding protein: structure and interactions with retinol, retinoids, and transthyretin. Vitam. Horm. 69 (2004) 271-295
4. Cogan U., Kopelman M., Mokady S., and Shinitzky M. Binding affinities of retinol and related compounds to retinol binding proteins. Eur. J. Biochem. 65 (1976) 71-78
5. Berni R., and Formelli F. In vitro interaction of fenretinide with plasma retinol-binding protein and its functional consequences. FEBS Lett. 308 (1992) 43-45
6. Sani B.P., Fulmer Y., and Hill D.L. N-(4-Hydroxyphenyl)retinamide: interactions with retinoid-binding proteins/receptors. Carcinogenesis 16 10 (1995) 2531-2534
7. Malpelli G., Folli C., and Berni R. Retinoid binding to retinol-binding protein and the interference with the interaction with transthyretin. Biochim. Biophys. Acta 1294 (1996) 48-54
8. Y. Han, T.V. Bui, N.L. Mata, A novel screening method for compounds which reduce serum retinol and arrest the accumulation of lipofuscin fluorophores in the RPE, Invest. Ophthalmol. Vis. Sci. 47 (2006) E-Abstract 2020.
9. Malone W., Perloff M., Corwell J., Sigman C., and Higley H. Fenretinide: a prototype cancer prevention drug. Expert Opin. Invest. Drugs 12 (2003) 1829-1842
10. Yang Q., Graham T.E., Mody N., Preitner F., Peroni O.D., Zabolotny J.M., Krotani K., Quadro L., and Kahn B.B. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436 (2005) 356-362
11. Graham T.E., Yang Q., Bluher M., Hammarstedt A., Ciaraldi T.P., Henry R.R., Wason C.J., Oberbach A., Jansson P.A., Smith U., and Kahn B.B. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N. Engl. J. Med. 354 (2006) 2552-2563
12. Radu R.A., Han Y., Bui T.V., Nusinowitz S., Bok D., Lichter J., Widder K., Travis G.H., and Mata N.L. Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases. Invest. Ophthalmol. Vis. Sci. 46 (2005) 4393-4401
13. Pope A.J. Introduction: LANCE vs. HTRF (or vice versa). J. Biomol. Screen. 4 (1999) 301-302
14. Mathis G. HTRF technology. J. Biomol. Screen. 4 (1999) 309-314
15. Zhou V., Han S., Brinker A., Klock H., Caldwell J., and Gu X.J. A time-resolved fluorescence resonance energy transfer-based HTS assay and a surface plasmon resonance-based binding assay for heat shock protein 90 inhibitors. Anal. Biochem. 331 (2004) 349-357
16. Wang Y., Klock H., Yin H., Wolff K., Bieza K., Niswonger K., Matzen J., Gunderson D., Hale J., Lesley S., Kuhen K., Caldwell J., and Brinker A. Homogeneous high-throughput screening assays for HIV-1 integrase 3beta-processing and strand transfer activities. J. Biomol. Screen. 10 (2005) 456-462
17. Coward P., Conn M., Tang J., Xiong F., Menjares A., and Reagan J.D. Application of an allosteric model to describe the interactions among retinol binding protein 4, transthyretin, and small molecule retinol binding protein 4 ligands. Anal. Biochem. 384 (2009) 312-320
18. Motani A., Wang Z., Conn M., Siegler K., Zhang Y., Liu Q., Johnstone S., Xu H., Thibault S., Wang Y., Fan P., Connors R., Le H., Xu G., Walker N., Shan B., and Coward P. Identification and characterization of a nonretinoid ligand for retinol-binding protein 4 which lowers serum retinol-binding 4 levels in vivo. J. Biol. Chem. 284 (2009) 7673-7680
19. Klock H.E., Koesema E.J., Knuth M.W., and Lesley S.A. Combining the polymerase incomplete primer extension method for cloning and mutagenesis with microscreening to accelerate structural genomics efforts. Proteins 71 (2008) 982-994
20. Lesley S.A., Kuhn P., Godzik A., Deacon A.M., Mathews I., Kreusch A., Spraggon G., Klock H.E., McMullan D., Shin T., Vincent J., Robb A., Brinen L.S., Miller M.D., McPhillips T.M., Miller M.A., Scheibe D., Canaves J.M., Guda C., Jaroszewski L., Selby T.L., Elsliger M.A., Wooley J., Taylor S.S., Hodgson K.O., Wilson I.A., Schultz P.G., and Stevens R.C. Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipeline. Proc. Natl. Acad. Sci. USA 99 (2002) 11664-11669
21. Zhang J.H., Chung T.D., and Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high-throughput screening assays. J. Biomol. Screen. 4 (1999) 67-73
22. McGovern S.L., Caselli E., Grigorieff N., and Shoichet B.K. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J. Med. Chem. 45 (2002) 1712-1722
23. McGovern S.L., Helfand B.T., Feng B., and Shoichet B.K. A specific mechanism of nonspecific inhibition. J. Med. Chem. 46 (2003) 4265-4272
24. Seidler J., McGovern S.L., Doman T.N., and Shoichet B.K. Identification and prediction of promiscuous aggregating inhibitors among known drugs. J. Med. Chem. 46 (2003) 4477-4486
25. Kawaguchi R., Yu J., Honda J., Whitelegge J., Ping P., Wiita P., Bok D., and Sun H. A membrane receptor for retinol-binding protein mediates cellular uptake of vitamin A. Science 315 (2007) 820-825
26. Kim S.R., Jang Y.P., Jockusch S., Fishkin N.E., Turro N.J., and Sparrow J.R. The all-trans-retinal dimer series of lipofuscin pigments in retinal pigment epithelial cells in a recessive Stargardt disease model. Proc. Natl. Acad. Sci. USA 104 (2007) 19273-19278
27. Maeda A., Maeda T., Golczak M., and Palczewski K. Retinopathy in mince induced by disrupted all-trans-retinal clearance. J. Biol. Chem. 283 (2008) 26684-26693
28. Zhou J., Kim S.R., Westlund B.S., and Sparrow J.R. Complement activation by bisretinoid constituents of RPE lipofuscin. Invest. Ophthalmol. Vis. Sci. 50 (2009) 1392-1399